Will New Covid Treatments Be as Elusive for Poor Countries as Vaccines?

Will New Covid Treatments Be as Elusive for Poor Countries as Vaccines?

“It’s not a coincidence that Merck has experience from H.I.V. — internally, with their leadership and culture, they know that if they don’t address the access challenges, they will be slammed,” said Dr. Moon, co-director of the Global Health Centre at the Graduate Institute of International and Development Studies in Geneva. Generic manufacturing it not … Read more